Table 1 Univariate analysis of epidemiologic and HIV infection data in 178 women and association with HPV
Variables | n (%) | HPV (%) | OR (95% CI)a | p valueb |
|---|---|---|---|---|
Age ranges (years) | ||||
18-30 | 28 (15.7) | 60.7 | 1.93 (0.94-1.99) | 0.13 |
31-40 | 60 (33.7) | 43.3 | 0.96 (0.47-1.95) | 0.89 |
> 40 | 90 (50.6) | 44.4 | 1.0 | |
Education (years) | ||||
< 8 | 85 (47.8) | 45.9 | 1.69 (0.93-3.06) | 0.84 |
≥ 8 | 93 (52.2) | 47.3 | 1.0 | |
Marital status | ||||
Married | 93 (52.2) | 45.2 | 1.0 | |
Unmarried | 31 (17.4) | 48.4 | 1.14 (0.46-2.77) | 0.75 |
Widowed | 54 (30.3) | 48.1 | 1.13 (0.55-2.33) | 0.72 |
Skin color | ||||
White | 114 (64.0) | 42.1 | 1.0 | |
Not white | 64 (36.0) | 54.7 | 1.66 (0.86-3.22) | 0.10 |
Menarche (years) | ||||
< 13 | 95 (53.4) | 43.2 | 0.74 (0.39-1.40) | 0.32 |
≥ 13 | 83 (46.6) | 50.6 | 1.0 | |
Age of sexual debut (years) | ||||
< 18 | 112 (62.9) | 45.5 | 0.89 (0.46-1.71) | 0.70 |
≥ 18 | 66 (37.1) | 48.5 | 1.0 | |
Sexual partners (number) | ||||
1 | 16 (9.0) | 56.2 | 1.0 | |
2-7 | 74 (41.6) | 44.6 | 0.63 (0.18-2.10) | 0.39 |
> 7 | 88 (49.4) | 46.6 | 0.68 (0.20-2.22) | 0.47 |
Parity (number) | ||||
0 | 20 (11.2) | 70.0 | 1.0 | |
1-2 | 67 (37.7) | 49.2 | 0.42 (0.12-1.35) | 0.10 |
≥ 3 | 91 (51.1) | 39.6 | 0.28 (0.09-0.88) | 0.01 |
History of Pap screening in the past three years | ||||
Yes | 143 (80.3) | 42.7 | 1.0 | |
No | 35 (19.7) | 62.9 | 2.27 (1.01-5.23) | 0.03 |
Hormonal contraceptive use | ||||
Yes | 135 (75.9) | 43.7 | 0.61 (0.29-1.30) | 0.16 |
No | 43 (24.1) | 55.8 | 1.0 | |
Gynecologic infections | ||||
Yes | 127 (71.3) | 48.0 | 1.22 (0.60-2.47) | 0.55 |
No | 51 (28.7) | 43.1 | 1.0 | |
Gynecologic infections (number) | ||||
0 | 55 (30.9) | 40.0 | 1.0 | |
1-2 | 93 (52.2) | 48.4 | 1.41 (0.68-2.92) | 0.32 |
≥ 3 | 30 (16.9) | 53.3 | 1.71 (0.64-4.64) | 0.23 |
Cigarette smoking | ||||
Yes | 35 (19.7) | 65.7 | 2.76 (1.15-6.67) | 0.01 |
No | 100 (56.2) | 41.0 | 1.0 | |
Ex-smoker | 43 (24.1) | 44.2 | 0.41 (0.15-1.14) | 0.05 |
Period of HIV infection (years) | ||||
< 5 | 76 (42.7) | 56.6 | 1.72 (0.79-3.75) | 0.13 |
5-10 | 51 (28.6) | 35.5 | 0.72 (0.30-1.72) | 0.41 |
> 10 | 51 (28.6) | 43.1 | 1.0 | |
HAART correct use | ||||
Yes | 141 (79.2) | 46.8 | 1.04 (0.47-2.28) | 0.92 |
No | 37 (20.8) | 45.9 | 1.0 | |
Current CD4+ T lymphocyte (cells/mm 3 ) | ||||
< 200 | 15 (8.4) | 66.7 | 2.76 (0.81-9.92) | 0.06 |
200-350 | 67 (37.6) | 56.3 | 1.78 (0.76-4.16) | 0.14 |
> 350 | 47 (26.4) | 42.0 | 1.0 | |
CD4+ T lymphocyte range (cells/mm 3 ) | ||||
< 200 | 64 (35.9) | 51.5 | 1.21 (0.53-2.76) | 0.62 |
200-350 | 67 (37.6) | 41.8 | 0.82 (0.36-1.85) | 0.59 |
> 350 | 47 (26.4) | 46.8 | 1.0 | |
Recent viral load (copies/ml) | ||||
< L min | 104 (58.4) | 43.3 | 1.0 | |
1-100.000 | 69 (38.8) | 49.3 | 1.27 (0.66-2.46) | 0.43 |
> 100.000 | 5 (2.8) | 80.0 | 5.24 (0.52-27.6) | 0.17 |
Viral load range (copies/ml) | ||||
1-100.000 | 50 (28.1) | 50.0 | 1.0 | |
> 100.000 | 128 (71.9) | 45.3 | 0.83 (0.41-1.68) | 0.57 |